C258H312Cl4F8N48O12 — CID 158553259
bis(1-[(3-chloro-4-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);1-[(4-chloro-3-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;1-[(4-chlorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;tris(1-[(3-fluoro-4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);bis(1-(3-fluoro-4-methylphenyl)-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);tris(1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one) (PubChem CID 158553259) has the molecular formula C258H312Cl4F8N48O12 and a molecular weight of 4571.45 g/mol. Its IUPAC name is bis(1-[(3-chloro-4-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);1-[(4-chloro-3-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;1-[(4-chlorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;tris(1-[(3-fluoro-4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);bis(1-(3-fluoro-4-methylphenyl)-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);tris(1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one).
| Compound Name | bis(1-[(3-chloro-4-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);1-[(4-chloro-3-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;1-[(4-chlorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;tris(1-[(3-fluoro-4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);bis(1-(3-fluoro-4-methylphenyl)-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);tris(1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one) |
|---|---|
| PubChem CID | 158553259 |
| Molecular Formula | C258H312Cl4F8N48O12 |
| Molecular Weight | 4571.45 g/mol |
| Exact Mass | 4566.39 |
| IUPAC Name | bis(1-[(3-chloro-4-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);1-[(4-chloro-3-fluorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;1-[(4-chlorophenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one;tris(1-[(3-fluoro-4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);bis(1-(3-fluoro-4-methylphenyl)-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one);tris(1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)piperazin-1-yl]pyrrolidin-2-one) |
| SMILES | Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3)C2=O)cc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(C)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(C)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(C)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(Cl)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(Cl)cc4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(F)c(Cl)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(F)c(Cl)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(c4ccc(C)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(c4ccc(C)c(F)c4)C3=O)CC2)nc1 |
| InChI | InChI=1S/3C22H27FN4O.3C22H28N4O.3C21H24ClFN4O.C21H25ClN4O.2C21H25FN4O/c3*1-16-3-6-21(24-14-16)26-11-9-25(10-12-26)20-7-8-27(22(20)28)15-18-5-4-17(2)19(23)13-18;3*1-17-3-6-19(7-4-17)16-26-10-9-20(22(26)27)24-11-13-25(14-12-24)21-8-5-18(2)15-23-21;2*1-15-2-5-20(24-13-15)26-10-8-25(9-11-26)19-6-7-27(21(19)28)14-16-3-4-18(23)17(22)12-16;1-15-2-5-20(24-13-15)26-10-8-25(9-11-26)19-6-7-27(21(19)28)14-16-3-4-17(22)18(23)12-16;1-16-2-7-20(23-14-16)25-12-10-24(11-13-25)19-8-9-26(21(19)27)15-17-3-5-18(22)6-4-17;2*1-15-3-6-20(23-14-15)25-11-9-24(10-12-25)19-7-8-26(21(19)27)17-5-4-16(2)18(22)13-17/h3*3-6,13-14,20H,7-12,15H2,1-2H3;3*3-8,15,20H,9-14,16H2,1-2H3;3*2-5,12-13,19H,6-11,14H2,1H3;2-7,14,19H,8-13,15H2,1H3;2*3-6,13-14,19H,7-12H2,1-2H3 |
| InChIKey | HPYZECPHVXJJHJ-UHFFFAOYSA-N |
| XLogP | 33.96 |
| TPSA | 476.16 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 46 |
| Heavy Atoms | 330 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4571.45 |
| LogP ≤ 5 | 33.96 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 48 |